The Johns Hopkins NIMH therapeutic core is staffed with drug discovery scientists most of which are seasoned experts with significant experience in the pharmaceutical sector. Our core was designed to complement the strength of academic research by bridging a gap between basic science and therapeutic application. Below are the specific skills of the NIMH Translational Core.
- Johns Hopkins Drug Discovery
- Research Project: Neutral Sphingomyelinase 2 (nSMase2)
- Research Project: Cystine/Glutamate Antiporter
- Ajit Thomas, Ph.D.
- Kaitlyn Huizar
- Louis Mueller
Neurotherapeutics Course 2020 - Dr. Barbara Slusher
Dr. Barbara Slusher discusses the evolving role of drug discovery in academia. To illustrate, Dr. Slusher traces an example prodrug across the drug development process — from bench to bedside.